D. Cucinotta et al., 1ST-PHASE INSULIN-RESPONSE TO INTRAVENOUS GLUCOSE IN CYSTIC-FIBROSIS PATIENTS WITH DIFFERENT DEGREES OF GLUCOSE-TOLERANCE, Journal of pediatric endocrinology, 7(1), 1994, pp. 13-17
The aim of our study was to determine whether first-phase insulin resp
onse to intravenous (i.v.) glucose could be used as a simple and rapid
test to identify cystic fibrosis (CF) patients at risk to develop dia
betes mellitus. Forty consecutive CF patients with normal fasting bloo
d glucose values but with different degrees of glucose tolerance on th
e standard oral glucose tolerance test (22 with normal glucose toleran
ce, 16 with impaired glucose tolerance, 2 with diabetes mellitus) and
12 normal subjects, matched for age and body mass index, underwent an
i.v. glucose bolus to evaluate early phase insulin release. When compa
red to the normal subjects, CF patients had significantly reduced basa
l (76 +/- 50 vs 108 +/- 30 pM/l, 2p<0.02) and glucose stimulated insul
in levels (1+3 min insulin=456 +/- 275 vs 951 +/- 170 pM/l, 2p<0.01).
Early phase insulin release, however, did not differentiate between CF
patients with normal and impaired glucose tolerance; also in the two
diabetic patients insulin levels did not clearly differ from those obs
erved in the other groups of CF subjects. In conclusion, first-phase i
nsulin response may identify an impairment of B-cell function in CF su
bjects; however, it does not discriminate between different degrees of
glucose tolerance, as determined by the oral glucose tolerance test a
nd, therefore, it does not reliably identify those patients who will e
ventually develop overt diabetes mellitus.